Dr Ben Turner

• Specialty: Consultant Neurologist, with practice covering multiple sclerosis (MS), migraine and chronic headache, epilepsy and seizures, dizziness, and neurodegenerative conditions

• Conditions seen: multiple sclerosis, migraine headache and other headache syndromes, epilepsy, seizures and blackouts, Alzheimer's disease, Huntington's disease, memory disorders, motor neurone disease (MND), brain tumours, spinal cord tumour, spinal disorders, stroke, concussion, peripheral neuropathy and peripheral nerve damage, movement disorders, tremors, muscle spasms, sensory disturbance, pins and needles, restless leg syndrome (RLS) and periodic limb movement disorder (PLMD), vertigo and dizziness

• Tests, treatments and procedures: Botox injections for migraines, greater occipital nerve injections for chronic headaches, migraine infusion therapy (Vyepti IV), ocrelizumab (Ocrevus) subcutaneous injection, natalizumab (Tysabri) treatment for multiple sclerosis, home video telemetry

• Often consulted by patients with: a new or established MS diagnosis, frequent or severe migraines not controlled by standard medication, or unexplained neurological symptoms such as numbness, tingling, tremors or memory problems

• Patient ages seen: 18 +

• Also: HSCT (stem cell transplant) lead for multiple sclerosis at Barts Health NHS Trust and a founding member of the London HSCT panel; has been clinical lead and lead for the Clinical Research Centre at Barts Health NHS Trust

• Language: English

Dr Ben Turner is a Consultant Neurologist at Welbeck’s Neurology centre in London. He assesses and treats a wide range of neurological conditions, with particular expertise in multiple sclerosis (MS), migraine and chronic headache, epilepsy and seizures, dizziness, and neurodegenerative conditions including Alzheimer’s disease, Huntington’s disease and motor neurone disease.

His practice includes investigating unexplained neurological symptoms such as numbness, tingling, pins and needles, tremors and memory problems, as well as managing established neurological conditions. Treatments and investigations available through his clinic include Botox injections and CGRP therapies for migraine, greater occipital nerve injectionsfor chronic headache, disease-modifying treatments for MS, and home video telemetry to investigate seizures.

His work in MS includes his role as HSCT (haematopoietic stem cell transplantation) lead for multiple sclerosis at Barts Health NHS Trust, as well as being a founding member of the London HSCT panel. HSCT is an intensive treatment that resets the immune system to stop it attacking the nervous system in people with aggressive or treatment-resistant MS. Developments in this area have made long-term suppression of MS a realistic treatment goal for appropriately selected patients.

Alongside his clinical practice, Dr Turner has been directly involved in clinical research into many of the disease-modifying treatments now used for MS, including teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, ocrelizumab, ofatumumab and siponimod. At Barts Health NHS Trust, he has also served as Clinical Lead and as lead for the Clinical Research Centre, which runs clinical trials investigating new treatments for neurological conditions including MS and headache.